Secret Fear-Campaign to STOP 21st June Unlocking Gains Momentum as Hancock Hypes Indian Variant
As the 21st of June nears we are witnessing the ramping-up of hysteria, not over the South African variant first earmarked but Indian Variant that is made out to be the killer virus that will have us scurrying for cover again.
For a month now the BBC have been running endless stories about a supposed apocalypse taking place in India, this is entirely fictitious.
"Up to three quarters of new UK Covid cases could be of the Indian variant" Health Secretary Matt Hancock has said, which is absolutely meaningless.
Gibraltar's government and Ministry of Propaganda are ramping up their coverage of cases in the plan to blame the unvaccinated and children – Opening Gib Could Be A Plan For The Next Lockdown – Picardo would make Franco Proud
Pandemics are Big Business - Is the INDIAN VARIANT Going to Be the Next One?
Big Pharma Is Already Preparing Vaccines For The Next Global Pandemic
Now that Pfizer and Moderna have demonstrated just how profitable a vaccine business can be during a global pandemic, drug companies around the world are rushing to prepare for either a resurgence of mutant COVID-19, or perhaps some new virus...
GlaxoSmithKline is investing in its vaccine business in order to get ahead of the next pandemic...
GSK is in talks with the British government to onshore more of its vaccine development and research capabilities, alongside production. GSK and its hedge fund backers are in the process of spinning off the company's consumer health division next year and leaving its biopharma and vaccine arms, businesses that Connor describes as the company's "crown jewels."
GSK and its partner Sanofi plan to start advanced trials with more than 37,000 people in coming weeks, with multiple formulations of the vaccine to better protect against variants such as those first found in South Africa and India.
Just like Pfizer's criminal history, Sanofi and GSK have a sorted past, ie: Corruption in Pharma: Sanofi Only the Latest Company Accused of Bribery – Intelligence Pharma. Paris-based Sanofi settled corruption charges with the U.S. Securities and Exchange Commission (SEC) for more than $25 million. The most notorious case of a biopharma bribery scandal was GlaxoSmithKline in China.